CytoSorbents' stock jumps on FDA authorization for its device in COVID-19 patients [MarketWatch]
Cytosorbents Corporation (CTSO)
Last cytosorbents corporation earnings: 11/5 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
cytosorbents.com
Company Research
Source: MarketWatch
Shares of CytoSorbents Corp. gained 28.7% in trading on Monday following a Food and Drug Administration announcement late on Friday that grants an emergency use authorization to the company's blood purification system for COVID-19 patients. An EUA is not an FDA approval; however, during the COVID-19 pandemic, this type of authorization allows companies to market their technologies to health care providers as treatments for patients with the novel coronavirus. CytoSorbents' technology, which is used to treat cytokine storms, is approved outside of the U.S., the company said in a news release. The EUA allows the CytoSorb product to be used in some adult patients with COVID-19 infections being treated in intensive care units with respiratory failure. CytoSorbents' stock has soared 118.1% year-to-date; the S&P 500 , in comparison, has dropped 13.6%.
Show less
Read more
Impact Snapshot
Event Time:
CTSO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTSO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTSO alerts
High impacting Cytosorbents Corporation news events
Weekly update
A roundup of the hottest topics
CTSO
News
- Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London [Yahoo! Finance]Yahoo! Finance
- Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in LondonPR Newswire
- Cytosorbents (NASDAQ:CTSO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.MarketBeat
- Cytosorbents (NASDAQ:CTSO) had its price target lowered by analysts at HC Wainwright from $1.00 to $0.75. They now have a "neutral" rating on the stock.MarketBeat
- Cytosorbents Corporation (CTSO) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
CTSO
Earnings
- 11/13/25 - Beat
CTSO
Sec Filings
- 11/20/25 - Form 4
- 10/3/25 - Form 8-K
- 9/16/25 - Form 8-K
- CTSO's page on the SEC website